The effects of berberine on the pharmacokinetics of ciclosporin A in healthy volunteers

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 28, Issue 1, 2006, Pages 25-29

  Xin, H W ^a   Wu, X C ^a   Li, Q ^a   Yu, A R ^a   Zhong, M Y ^a   Liu, Y Y ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Berberine; Ciclosporin A; CYP3A4; P glycoprotein; Pharmacokinetics

Indexed keywords

BERBERINE; CYCLOSPORIN A;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG HALF LIFE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; MALE; NORMAL HUMAN;

ADULT; BERBERINE; BIOLOGICAL AVAILABILITY; CYCLOSPORINE; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INHIBITORS; GASTRIC EMPTYING; HUMANS; INTESTINE, SMALL; LIVER; MALE;

EID: 33645337094     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2006.28.1.962774     Document Type: Article

References (28)

1. Yee, G.C. Pharmacokinetic interactions between ciclosporin and other drugs. Transplant Proc 1990, 22: 1203-7.
2. Hebert, M.F., Roberts, J.P., Prueksaritanont, T., Benet, L.Z. Bioavailability of ciclosporin with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther 1992, 52: 453-7.
3. Gupta, S.K., Bakran, A., Johnson, R.W.G., Rowland, M. Cyclosporin-erythromycin interaction in renal transplant patients. Br J Clin Pharmacol 1989, 27: 475-81.
4. Ducharme, M.P., Provenzano, R., Dehoorne-Smith, M., Edwards, D. Trough concentration of ciclosporin in blood following administration with grapefruit juice. Br J Clin Pharmacol 1993, 36: 457-9.
5. Pinto, A.G., Horlander, J., Chalasani, N. et al. Diltiazem inhibits human intestine cytochrome P4503A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein. Br J Clin Pharmacol 2005, 59: 440-6.
6. Watkins, P.B. The role of cytochromes P-450 in ciclosporin metabolism. J Am Acad Dermatol 1990, 23: 301-11.
7. Jones, T.E. The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations. Clin Pharmacokinet 1997, 32: 357-67.
8. Martin, J.E., Daoud, A.J., Schroeder, T.J., First, M.R. The clinical and economic potential of cyclosporin drug interactions. Pharmacoeconomics 1999, 15: 317-37.
9. Patton, P.R., Brunson, M.E., Pfaff, W.W. et al. A preliminary report of diltiazem and ketoconazole. Their ciclosporin-sparing effect and impact on transplant outcome. Transplantation 1994, 57: 889-92.
10. Li, Q., Wu, X.C., Xin, H.W. et al. Clinical study on increased blood concentration of cyclosporin A by berberine hydrochloride in renal transplanted recipients. Chin J Organ Transplant 2001, 22: 209-11.
11. Wu, X.C., Li, Q., Xin, H.W., Yu, A.R., Zhong, M.Y. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients-Clinical and pharmacokinetic study. Eur J Clin Pharmacol 2005, 61: 567-72.
12. Lu, S.K., Callahan, S.M., Brunner, L.J. Suppression of hepatic CYP3A1/2 and CYP2C11 by ciclosporin is not mediated by altering growth hormone levels. J Pharmacol Exp Ther 2003, 305: 331-7.
13. Kolars, J.C., Schmiedlin-Ren, P., Schuetz, J.D., Fang, C., Watkins, P.B. Identification of rifampin-inducible P4503A4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992, 90: 1871-8.
14. Watkins, P.B. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol Clin North Am 1992, 221: 511-26.
15. Gomez, D.Y., Wacher, V.J., Tomlanovich, S.J., Hebert, M.F., Benet, L.Z. The effects of ketoconazole on the intestinal metabolism and bioavailability of ciclosporin. Clin Pharmacol Ther 1995, 58: 15-9.
16. Durr, D., Stieger, B., Kullak-Ublick, G.A. et al. St. John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000, 68: 598-604.
17. Bauer, S., Stormer, E., Johne, A. et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St. John's wort in renal transplant patients. Br J Clin Pharmacol 2003, 55: 203-11.
18. Bao, L., Li, B., Yang, B. et al. Study on the pharmacokinetics of berberine after oral administration in healthy volunteers. Chin Pharmacol Bull 1997, 13: 95.
19. Xin, H.W., Wu, X.C., Li, Q., Zhong, M.Y., Yu, A.R., Zhu, M. Effects of berberine hydrochloride and coadministration with ciclosporin A on liver microsomal cytochrome P450 isoenzyme in mice. Chin Pharm J 2002, 37: 496-9.
20. Xin, H.W., Wu, X.C., Li, Q. et al. Effects of coadministration of berberine chloride with cyclosporin on liver microsomal cytochrome P450 isoenzyme and mdrl in rats. Chin Pharmacol Bull 2002, 18: 397-401.
21. Xin, H.W., Wu, X.C., Li, Q. et al. Effects of berberine chloride and coadministration with cyclosporin on CYP3A1 in rat liver and small intestine. Chin J Clin Pharmacol Ther 2004, 9: 565-8.
22. Xin, H.W., Wu, X.C., Li, Q. et al. Effects of berberine hydrochloride and its coadministration with cyclosporin on CYP3A2 expression in rat liver and small intestine. Chin Pharm J 2005, 37: 496-9.
23. Chatterjee, P., Franklin, M.R. Human cytochrome P450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab Dispos 2003, 31: 1311-91.
24. Pan, G.Y., Wang, G.J., Liu, X.D., Fawcett, J.P., Xie, Y.Y. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 2002, 91: 193-7.
25. Maeng, H.J., Yoo, H.J., Kim, I.W., Song, I.S., Chung, S.J., Shim, C.K. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci 2002, 91: 2614-21.
26. Lin, H.L., Liu, T. Y., Lui, W.Y., Chi, C.W. Up-regulation of multidrug resistance transporter expression by berberine in human and marine hepatoma cells. Cancer 1999, 85: 1937-42.
27. He, L., Liu, G.Q. Effects of various principles from Chinese herbal medicine on rhodamine 123 accumulation in brain capillary endothelial cells. Acta Pharmacol Sin 2002, 23: 591-6.
28. Zhuang, P., Chen, R., Liang, J., Gu, R., Gao, L. Studies on medicinal effects of Rhizoma coptidis on digestive function. Chin J Inform Traditional Chin Med 2003, 10: 28-9.